Cellbion Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -50.71%
- Ebitda 24.86%
- Net Worth 25.13%
- Total Assets -28.60%
About Cellbion Lifesciences
Cellbion Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 April 2007 and has a history of 17 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Brijesh Soni and Sunilkumar Gupta serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2007PTC170041
-
Company No.
170041
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Apr 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cellbion Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brijesh Soni
|
Director | 30-Mar-2015 | Current |
|
Sunilkumar Gupta
|
Director | 16-Oct-2012 | Current |
Financial Performance of Cellbion Lifesciences.
Cellbion Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 50.71% decrease in profit. The company's net worth Soared by an impressive increase of 25.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cellbion Lifesciences?
In 2022, Cellbion Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Maharashtra Aldehydes And Chemicals LtdSunilkumar Gupta is a mutual person
-
Laxmi Natural Products Private LimitedBrijesh Soni and Sunilkumar Gupta are mutual person
-
Viva Lifesciences Private Limited
Brijesh Soni and Sunilkumar Gupta are mutual person
-
Laxmi Tank Terminal Private Limited
Brijesh Soni is a mutual person
-
Laxmi Capital Services Private Limited
Sunilkumar Gupta is a mutual person
-
Cleanwin Energy One LlpBrijesh Soni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cellbion Lifesciences?
Unlock and access historical data on people associated with Cellbion Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellbion Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellbion Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
